QC
TECH icon

Quent Capital’s Bio-Techne TECH Stock Holding History

Quent Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37K Sell
76
-297
-80% -$16K ﹤0.01% 1349
2026
Q1 		$19.5K Buy
373
+46
+14% +$2.76K ﹤0.01% 998
2025
Q4 		$19.2K Hold
327
– – ﹤0.01% 1002
2025
Q3 		$18.2K Buy
+327
New +$17.5K ﹤0.01% 889
2025
Q2 		– Sell
-147
Closed -$8.62K – 1133
2025
Q1 		$8.62K Hold
147
– – ﹤0.01% 926
2024
Q4 		$10.6K Hold
147
– – ﹤0.01% 923
2024
Q3 		$11.8K Hold
147
– – ﹤0.01% 984
2024
Q2 		$10.5K Hold
147
– – ﹤0.01% 978
2024
Q1 		$10.3K Hold
147
– – ﹤0.01% 1010
2023
Q4 		$11.3K Buy
147
+11
+8% +$725 ﹤0.01% 948
2023
Q3 		$9.26K Hold
136
– – ﹤0.01% 947
2023
Q2 		$11.1K Hold
136
– – ﹤0.01% 914
2023
Q1 		$9.96K Hold
136
– – ﹤0.01% 921
2022
Q4 		$11.3K Buy
136
+60
+79% +$4.76K ﹤0.01% 874
2022
Q3 		$5K Hold
76
– – ﹤0.01% 990
2022
Q2 		$7K Sell
76
-96
-56% -$9K ﹤0.01% 905
2022
Q1 		$19K Buy
+172
New +$17.7K ﹤0.01% 802

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quent Capital's TECH Position: Q2 2026 in Review

Quent Capital reduced its Bio-Techne (TECH) stake by 80% in Q2 2026, selling an estimated $16K and leaving 76 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Quent Capital first reported a position in TECH in Q1 2022 and has held it in 17 quarters since. The position peaked at $19.5K in Q1 2026. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Quent Capital held 76 shares of Bio-Techne worth $5.37K as of Q2 2026.
  • Quent Capital sold 297 Bio-Techne shares in Q2 2026, an estimated $16K.
  • Bio-Techne made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1349 holding.
  • Quent Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 17 quarters since.
  • Quent Capital's Bio-Techne position peaked at $19.5K in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.